Novo Nordisk Phases Out Rybelsus for Oral Ozempic Pill as Generic Semaglutide Hits Canada
Novo Nordisk is phasing out Rybelsus and introducing a newer oral semaglutide formulation as the Ozempic pill, which requires a new prescription and lower doses. Generic semaglutide from Dr. Reddy's and Apotex is entering Canada, prompting Novo Nordisk to cut Ozempic prices for some patients without coverage. GoodRx and Novo Nordisk also launched self-pay pricing for oral Ozempic starting at $149 per month.